Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Akso Health Group

    NASDAQ: HX · Real-Time Price · USD
    2.24
    -0.10 (-4.27%)
    At close: Dec 16, 2021, 6:00 AM

    Akso Health Statistics

    Share Statistics

    Akso Health has 23.83M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 23.83M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 20.21M

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 20.62K, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 20.62K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -1.81 and the forward PE ratio is null. Akso Health's PEG ratio is 0.03.

    PE Ratio

    n/a
    		 -1.81

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 7.09

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.12

    P/FCF Ratio

    n/a
    		 12.67

    PEG Ratio

    n/a
    		 0.03
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Akso Health.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 39.52, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 39.52

    Quick Ratio

    n/a
    		 39.46

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 1.48

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $21,365.82

    Profits Per Employee

    n/a
    		 $-83,706.05

    Employee Count

    n/a
    		 113

    Asset Turnover

    n/a
    		 0.02

    Inventory Turnover

    n/a
    		 11.99

    Taxes

    Income Tax

    n/a
    		 24.99K

    Effective Tax Rate

    n/a
    		 -0.27%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 1.47, so Akso Health's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.47

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 n/a

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 n/a

    Average Volume (20 Days)

    n/a
    		 2,959,035

    Income Statement

    In the last 12 months, Akso Health had revenue of 2.41M and earned -9.46M in profits. Earnings per share was -0.63.

    Revenue

    n/a
    		 2.41M

    Gross Profit

    n/a
    		 122.13K

    Operating Income

    n/a
    		 -8.64M

    Net Income

    n/a
    		 -9.46M

    EBITDA

    n/a
    		 n/a

    EBIT

    n/a
    		 -9.09M

    Earnings Per Share (EPS)

    n/a
    		 -0.63
    Full Income Statement

    Balance Sheet

    The company has 85.17M in cash and 2M in debt, giving a net cash position of 83.17M.

    Cash & Cash Equivalents

    n/a
    		 85.17M

    Total Debt

    n/a
    		 2M

    Net Cash

    n/a
    		 83.17M

    Retained Earnings

    n/a
    		 -63.93M

    Total Assets

    n/a
    		 32.52M

    Working Capital

    n/a
    		 9.34M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 1.35M and capital expenditures 0, giving a free cash flow of 1.35M.

    Operating Cash Flow

    n/a
    		 1.35M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 1.35M

    FCF Per Share

    n/a
    		 0.03
    Full Cash Flow Statement

    Margins

    Gross margin is 5.06%, with operating and profit margins of -357.78% and -391.78%.

    Gross Margin

    n/a
    		 5.06%

    Operating Margin

    n/a
    		 -357.78%

    Pretax Margin

    n/a
    		 -376.57%

    Profit Margin

    n/a
    		 -391.78%

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 -357.78%

    FCF Margin

    n/a
    		 55.97%

    Dividends & Yields

    HX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for HX.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Aug 24, 2020. It was a backward split with a ratio of 1:3.

    Last Split Date

    n/a
    		 Aug 24, 2020

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:3

    Scores

    Altman Z-Score

    n/a
    		 -8.03

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist